Document Detail


Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients.
MedLine Citation:
PMID:  15752936     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Patients with hypertension are at high risk for the development of left ventricular dysfunction (LVD). Echocardiography is considered to be the gold standard for diagnosis of LVD; but its cost, complexity, and availability prevents its use for frequent evaluation. Brain natriuretic peptide (BNP) and N-terminal BNP (NT-BNP) can identify heart failure in dyspneic patients. Impedance cardiography (ICG) is a noninvasive method of measuring hemodynamic and electromechanical timing parameters. The objective of this study was to determine the ability of BNP, NT-BNP, and ICG to detect the presence of LVD in patients with hypertension. METHODS: A convenience sample of subjects undergoing echocardiography who had a history of hypertension or current systolic blood pressure >/=140 mm Hg were enrolled and retrospectively evaluated. Patients with known LVD were excluded. Diagnosis of LVD was determined by the presence of systolic or diastolic dysfunction, valvular or wall motion abnormalities, or left ventricular hypertrophy. RESULTS: A total of 193 subjects were enrolled: 189 men and four women, age 68.8 +/- 11.7 years. Multivariate regression analysis of history and symptoms, BNP, and ICG parameters identified significant predictor variables for LVD including cardiac index (P = .005), left cardiac work index (P = .008), BNP (P = .017), arrhythmia (P = .023), angina (P = .034), and systemic vascular resistance (P = .048). Receiver operating characteristic (ROC) analysis determined the area under the ROC curve (AUC) of BNP (0.60), NT-BNP (0.67), ICG velocity index (0.66), composite ICG (0.66), ICG combined with BNP (0.70), and ICG combined with NT-BNP (0.73). CONCLUSIONS: In this high-risk hypertensive population, BNP, NT-BNP, and ICG were useful to identify the presence of LVD. The use of ICG with natriuretic peptide testing may improve the ability to detect LVD.
Authors:
Vikas Bhalla; Susan Isakson; Meenakshi A Bhalla; Jeannette P Lin; Paul Clopton; Nancy Gardetto; Alan S Maisel
Related Documents :
2136966 - Appearance of atrial natriuretic peptide in the ventricles in patients with myocardial ...
7990976 - Hypoxia induces release of atrial natriuretic peptide in rat atrial tissue: a role for ...
11579366 - Natriuretic peptides in patients with aortic stenosis.
15748596 - Circulating cardiovascular markers and mediators in acute illness: an update.
9236376 - Ross-konno procedure with interrupted aortic arch repair in a premature neonate.
16788326 - Sudden death associated with anomalous coronary origin and obstructive coronary disease...
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  American journal of hypertension     Volume:  18     ISSN:  0895-7061     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-03-08     Completed Date:  2005-06-20     Revised Date:  2009-02-24    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  United States    
Other Details:
Languages:  eng     Pagination:  73S-81S     Citation Subset:  IM    
Affiliation:
Division of Cardiology and the Department of Medicine, Veterans Affairs Medical Center and University of California, San Diego, San Diego, California 92161, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Area Under Curve
Cardiography, Impedance*
Echocardiography
Female
Humans
Hypertension / complications*
Male
Middle Aged
Multivariate Analysis
Natriuretic Peptide, Brain / blood*
Nerve Tissue Proteins / blood
Peptide Fragments / blood
ROC Curve
Retrospective Studies
Ventricular Dysfunction, Left / blood,  diagnosis*,  etiology*,  ultrasonography
Chemical
Reg. No./Substance:
0/Nerve Tissue Proteins; 0/Peptide Fragments; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prognostic value of hemodynamic findings from impedance cardiography in hypertensive stroke.
Next Document:  Systolic blood pressure does not reliably identify vasoactive status in chronic heart failure.